StreetInsider
Log in to your account:
Log in
Signup
Home
EPS Insider
Event Calendar
Conferences
Classic Site
Upgrade to SI Premium - Free Trial
Edwards Lifesciences (EW) shares rally on Evoque FDA approval
February 2, 2024 11:26 AM
Edwards Lifesciences (NYSE: EW) shares are rallying Friday after the company’s EVOQUE tricuspid valve replacement system was approved by the ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
Categories
Analyst Comments
FDA
Hot FDA News
Next Articles
Edwards Lifesciences (EW) EVOQUE Valve Replacement System First Transcatheter Therapy to Earn FDA Approval for Tricuspid Valve
February 2, 2024 11:03 AM
Wells Fargo Upgrades Edwards Lifesciences (EW) to Overweight, 'We believe that asymptomatic AS is now a free call option'
February 2, 2024 10:13 AM
Edwards’ EVOQUE Valve Replacement System First Transcatheter Therapy to Earn FDA Approval for Tricuspid Valve
February 2, 2024 7:00 AM
Form 4 Edwards Lifesciences For: Feb 01 Filed by: Ullem Scott B.
February 1, 2024 5:52 PM
Midday movers: Boeing flies, Alphabet flops, and more
January 31, 2024 7:57 AM
